A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2004
11/11/2004	US20040224951 5,6-Fused uracil derivatives as matrix metalloproteinase inhibitors
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224933 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224881 drug screening for chloride channel blockers; osteoporosis, osteolytic cancer, osteopetrosis, Paget's disease; anticarcinogenic agents
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery
11/11/2004	US20040224026 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040224022 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040223978 determining calciotropic activity of a preparation of Padina pavonica by culturing osteoblasts in a medium rich in calcium ions; adding the algae after complete development; eliminating calcium ions; acidifying to destroy extracellular matrix; filtering; determining concentration of fixed calcium ions
11/11/2004	US20040223953 Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects
11/11/2004	US20040223911 Stabilized therapeutic and imaging agents
11/11/2004	DE10257824B4 Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen Composition for the treatment of pain, particularly for the treatment of joint pain
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases
11/10/2004	EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1475095A1 Percutaneous preparations
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474393A1 Aryl ureas as kinase inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
11/10/2004	EP1474122A2 Compounds for blocking androgen receptors
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004	EP0790056B1 Use of composition for preventing or treating diseases caused by abnormalities in cartilage tissues
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545415A Bone anabolic compounds and methods of use
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1544068A Antigout medicinal composition and its preparing method
11/10/2004	CN1544057A Externally applied medicine for treating ischemic necrosis of femoral head and its preparation
11/10/2004	CN1544056A Oral medicine for treating ischemic necrosis of femoral head and its preparation
11/10/2004	CN1544054A Oral liquid for treating numbness pain
11/10/2004	CN1544034A Songqi traumatic injury treating ointment
11/10/2004	CN1544019A Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation
11/10/2004	CN1543940A Medicine for prevention and treatment of osteoporosis by red sage root and water extract thereof
11/10/2004	CN1543857A Health food having functions of postponing senescence and increasing bone mineral density
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/10/2004	CN1174964C Vitamin D3 Analogs
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174768C Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylosis and intervertebral disk protrusion and its preparation method
11/10/2004	CN1174762C Compound Chinese medicine preparation for curing cervical spondylotic myelopathy and cervical spondylotic radiculopathy
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004093897A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	WO2004093868A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	WO2004083185A3 Phenyl substituted imidazole derivatives
11/04/2004	WO2004067063A3 Improved formulations for transmucosal vaginal delivery of bisphosphonates
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases
11/04/2004	US20040220680 Tissue repair matrix
11/04/2004	US20040220574 Device from naturally occuring biologically derived materials
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220234 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220143 Oral delivery of macromolecules
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds,
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219230 Compositions for preparing external carbon dioxide agents
11/04/2004	US20040219220 Therapeutic agents
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety

1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 820